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Abstract
Background: Anemia is more often seen in older patients. As the mean age of hip fracture patients is rising,
anemia is common in this population. Allogeneic blood transfusion (ABT) and anemia have been pointed out as
possible risk factors for poorer outcome in hip fracture patients.
Methods: In the timeframe 2005-2010, 1262 admissions for surgical treatment of a hip fracture in patients aged 65
years and older were recorded. Registration was prospective from 2008 on. Anemic and non-anemic patients
(based on hemoglobin level at admission) were compared regarding clinical characteristics, mortality, delirium
incidence, LOS, discharge to a nursing home and the 90-day readmission rate. Receiving an ABT, age, gender, ASA
classification, type of fracture and anesthesia were used as possible confounders in multivariable regression analysis.
Results: The prevalence of anemia and the rate of ABT both were 42.5%. Anemic patients were more likely to be
older and men and had more often a trochanteric fracture, a higher ASA score and received more often an ABT. In
univariate analysis, the 3- and 12-month mortality rate, delirium incidence and discharge to a nursing home rate
were significantly worse in preoperatively anemic patients.
In multivariable regression analysis, anemia at admission was a significant risk factor for discharge to a nursing
home and readmission < 90 days, but not for mortality. Indication for ABT, age and ASA classification were
independent risk factors for mortality at all moments, only the mortality rate for the 3-12 month interval was not
influenced by ABT. An indication for an ABT was the largest negative contributor to a longer LOS (OR 2.26, 95% CI
1.73-2.94) and the second largest for delirium (OR 1.67, 95% CI 1.28-2.20).
Conclusions: This study has demonstrated that anemia at admission and postoperative anemia needing an ABT
(PANT) were independent risk factors for worse outcome in hip fracture patients. In multivariable regression
analysis, anemia as such had no effect on mortality, due to a rescue effect of PANT. In-hospital, 3- and 12-month
mortality was negatively affected by PANT, with the main effect in the first 3 months postoperatively.
Background
Due to the ageing of the Western population, the num-
ber of elderly people will increase. Although age-
adjusted incidence of hip fractures in many countries,
like the US and Sweden, declined in the population of
50 years and older, there is a right-shift in hip fracture
distribution towards the highest age groups [1]. These
old patients have several co-morbidities, often described
as the “frailty syndrome” [2]. One of the typical features
of this syndrome is an anemic status [2]. Increasing evi-
dence suggests that low hemoglobin concentration is
common in elderly patients and adversely affects mor-
bidity and mortality, especially if they are in need of sur-
gery [2-5].
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Several studies on anemia in hip fracture patients
reported on increased morbidity, prolonged admission,
higher readmission rate and increased mortality rate
[6-8]. Studies on allogeneic blood transfusion (ABT) in
hip fracture patients show ambivalent findings regarding
outcome and mortality [9-14].
In this study, the effect of preoperative hemoglobin
level and perioperative ABT was evaluated in a large
cohort follow-up study of 1262 admissions for surgical
treatment for hip fracture in patients of 65 years and
older. The focus of our analysis was on mortality, inci-
dence of delirium, length of hospital stay, discharge to a
nursing home and the 90-day readmission rate.
Methods
An observational cohort study was conducted on hip
fracture patients admitted to a 350- and a 450-bed
teaching hospital in The Hague and Delft.
Aim of the study
To determine whether anemia at admission and perio-
perative allogeneic blood transfusion (ABT) have an
independent negative effect with mortality, occurrence of
a delirium, length of hospital stay (LOS), discharge to a
nursing home and 90-day readmission rate in surgically
treated hip fracture patients, aged 65 years and older.
Delirium has been chosen, as it is one of the most serious
and most common major in-hospital complications.
Patients and methods
All patients were extracted from our digital database
that contains all consecutive hip fracture patients,
admitted from January 2005 to January 2010. Data were
collected retrospectively for patients in the timeframe
2005-2007 and prospectively for those in the period
2008-2009.
The exclusion criteria for this study were: age < 65
years, a pathologic hip fracture, a high-energy injury and
conservative treatment. Duration of follow-up in all
patients was 12 months. This resulted in a cohort of
1262 admissions for a hip fracture, in 1222 patients.
From the hospital’s records (both digital and paper
files), age, gender, ASA classification, type of fracture,
type of treatment, type of anesthesia, pre- and post-
operative hemoglobin level, perioperative need for an
ABT, occurrence of a delirium, LOS and discharge loca-
tion were collected onto a case record form (CRF) [15].
Diagnosis of delirium was based on criteria of the
DSM IV [16]. Signs of a delirium are recorded in the
medical and nursing records as a standard part of docu-
mentation of the daily characteristics of a patient. Delir-
ium incidence in this series was scored based on these
medical and nursing staff records. To calculate the 90-
day readmission rate, all readmissions within 90 days
after discharge were extracted from the digital hospital
admission registration system. Postoperative mortality
has been documented meticulously by repeated consul-
tation of the population registers of the counties in the
region of both hospitals as well as the hospital’s patient
registration systems. If present, readmissions and date of
death were recorded at the CRF. As of 2008, all data
were recorded prospectively in the CRF. All fore men-
tioned data were complete, both in the retrospective
and prospective series and was performed by authors
AV, BB, PP and AN.
Approval from the local ethical committee was not
obtained, as this is an observational study without an
intervention. Therefore, it is an evaluation of usual care
as a part of good clinical practice. Since data could not
be traced back to the individual patient there were no
privacy issues.
Anemia and ABT policy
In all patients the hemoglobin level was measured at
admission. Anemia at admission was defined based on
the criteria of the World Health Organization (WHO)
[17]. These criteria classify anemia as a hemoglobin
level below 7.5 mmol/L (12 g/dL) in women and below
8.1 mmol/L (13 g/dL) in men. They were tested and
found sufficient for elderly by Izaks et al in their study
on mortality in elderly patients [18].
In the Netherlands, the national CBO guideline advises
ABT for subjects aged > 60 years when hemoglobin level
drops below 5.0 mmol/L (8.0 g/dL) in the general popula-
tion or 6.0 mmol/L (9.7 g/dL) if the patient has a serious
cardiac condition or when anemia becomes symptomatic
[19]. This guideline is general practice in both hospitals.
Hemoglobin level was measured on the first postopera-
tive day as a routine and if necessary repeated thereafter
based on clinical judgment.
Statistical analysis
Demographic continuous data are presented as means,
with standard deviations (SD). Categorical data are pre-
sented as the number of subjects in the category, along
with the percentages. Chi-square test and Fisher’s exact
test were used for comparing groups of categorical data.
The cohort was compared regarding differences in
clinical characteristics and outcome between the anemic
and non-anemic patients, based upon hemoglobin level
at admission.
Univariate analysis performed to test the association
between anemia and mortality (in-hospital, 3- and 12-
month), delirium, LOS categories (≤ versus > 11 days),
discharge to a nursing home and 90-day readmission
rate. Separate logistic regression analyses were executed
for each outcome, for the mortality Cox proportional
hazards regression analysis was used to calculate the
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hazard ratio and 95% confidence interval. In these ana-
lyses, correction was performed for the possible con-
founders; age, gender, perioperative risk (ASA
classification I/II or III/IV), receiving an ABT, type of
fracture (neck of femur, (inter-) trochanteric or subtro-
chanteric), and type of anesthesia (general or spinal).
Because of the clinical relation between the anemia and
receiving an ABT collinearity diagnostics of the logistic
regression models were examined.
To robustify the analysis for LOS, this parameter was
changed into a binary summary outcome, i.e. ≤ or > 11
days (the median), as the distribution of the value LOS
was very wide.
Patients classified ASA I or II and III or IV were com-
bined to two groups, as the separate groups of ASA I (n
= 82) and ASA IV (n = 50) classified patients were too
small to be analyzed separately.
P-values lower than 0.05 were considered statistically
significant. Odds ratios are displayed with a 95% confi-
dence interval if the p-value < 0.05. All data were ana-
lyzed in SPSS 17.0 (SPSS Inc. Chicago, USA).
Results
Clinical characteristics
1262 admissions for a surgical treatment of a hip frac-
ture (1222 patients) were extracted from the database;
932 (73.9%) were female. Mean (SD) age was 83.6 (7.1)
years and mean (SD) follow-up was 3.5 (1.4) years.
Mean (SD) hemoglobin level at admission was 7.7 (1.0)
mmol/l. According to the WHO criteria, 536 patients
(42.5%) were anemic [17]. Transfusion of one or more
unit(s) of allogeneic erythrocytes was given to 536
patients (42.5%), in the large majority (97.9%) postopera-
tively. Surgery within 24 hours after admission was per-
formed in 84.4% of all patients. Overall mortality was
40.4% (510 of 1262 patients).
Anemic versus non-anemic patients
The patients were divided in an anemic and non-anemic
group, based on the hemoglobin level at admission; clin-
ical characteristics of the two populations are shown in
Table 1.
The anemic group was significantly different from the
non-anemic regarding age, gender, ASA, fracture distri-
bution and ABT rate. There was no significant differ-
ence in mean follow-up. The relative risks for the
different outcome parameters according to univariate
analysis are presented in table 2. In this analysis, LOS
and the in-hospital and 3-12 month interval mortality
rate were not significantly different between both
groups.
The 90-day readmission rate was significantly higher
in anemic patients. Readmission for an orthopaedic rea-
son (surgical site infection, revision operation or a con-
tralateral hip fracture) was necessary in 43.5% (30 of 69)
of the anemic patients and in 36.9% (24 of 65) of the
non-anemics.
Multivariable logistic and Cox regression analysis
The Spearman’s correlation coefficient between anemia
and an ABT was low (0.38, p < 0.001) and the tolerance
and VIF values indicated no multicollinearity.
Anemia at admission was not a significant indepen-
dent risk factor for mortality at any moment in multi-
variable Cox regression analysis (table 3). Receiving an
ABT was a significant independent risk factor for in-
hospital, 3- and 12-month mortality, as were higher age
and ASA classification in all patients (both anemic and
non-anemic). However, receiving an ABT was not a risk
factor for the mortality in the 3 to 12 month interval.
Anemia was a significant independent risk factor for dis-
charge to a nursing home and readmission within 90
days. The odds ratio for anemia in the analysis for LOS
Table 1 Relative risks for different demographic characteristics in anemic and non-anemic patients
Outcome Anemic Non-anemic RR (CI) P-value
n = 536 n = 726
mean age in years (SD) 84.9 (6.9) 82.6 (7.0) n/a < 0.001
mean follow-up in months (SD) 42.7 (16.9) 42.2 (15.9) n/a 0.578
Male gender 170 (31.7) 160 (22.0) 1.31 (1.15-1.50) < 0.001
ASA III/IV 200 (37.3) 201 (27.7) 1.28 (1.12-1.45) < 0.001
Fracture type
-neck of femur 252 (47.0) 450 (62.0) < 0.001*
-(inter) trochanteric 266 (49.6) 256 (35.3) 0.70 (0.62-0.80) < 0.001**
-subtrochanteric 18 (3.4) 20 (2.8)
Spinal anesthesia 494 (92.2) 684 (94.2) 0.84 (0.67-1.05) 0.149
ABT 309 (57.6) 153 (21.1) 2.36 (2.08-2.68) < 0.001
Values are given as number (percentage), unless mentioned otherwise.
* P-value comparing 3 treatment groups, **RR and p-value comparing neck of femur with (inter-) trochanteric fractures.
RR = relative risk; CI = confidence interval; ASA = American Society of Anesthesiologists Physical Status classification, ABT = allogeneic blood transfusion.
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was 0.63 when adjusted for ABT and age. The latter two
both had an independent negative impact on LOS (OR
2.12 and 1.06). This meant that anemic patients had a
shorter stay in hospital than non-anemic patients, when
they were younger and did not receive an ABT. For the
outcome parameters besides mortality, i.e. discharge to a
nursing home, delirium, 90-day readmission rate and a
LOS > 11 days, age played a more important role than
ASA classification. Gender and type of anesthesia were
of little importance. Type of hip fracture was not a sig-
nificant independent contributor to any of our outcome
parameters in multivariable analysis.
Anemia effecting ABT and vice versa
Mortality in patients with anemia at admission (21.1%)
was higher than in non-anemics (12%, p < 0.001) and
mortality in all patients that received an ABT (22.7%)
was higher compared to those that did not (11.9%, p <
0.001).
The in-hospital mortality rate of anemic patients that
received an ABT (6.5%) compared to those who did not
(4.4%), was comparable (p = 0.30). However, the mortal-
ity rates in preoperative non-anemic patients who
received an ABT compared to those who did not were
respectively 9.8% and 2.8% (p < 0.001).
The 3-month mortality in anemic patients was 24.3%
in transfused and 16.7% in non-transfused patients (p =
0.035) and in non-anemic patients rates 19.6% and 9.9%
(p = 0.001) in transfused and non-transfused patients
respectively.
The relative risk (RR) for 3-month mortality in patients
with anemia at admission is significantly increased in
patients that did not receive an ABT (RR 1.49, CI 1.13-
1.96, p = 0.07) this was not the case in those that did
receive an ABT (RR 1.09, CI 0.95-1.26, p = 0.26).
As demonstrated in Figure 1 and 2, this effect of trans-
fusion on mortality between anemic and non-anemic
patients disappeared after about 3 months; the curves of
anemic and non-anemic patients that receive an ABT
(Figure 2) are parallel the first 90 days whereas the curves
of those that do not receive an ABT diverge (Figure 1).
Mortality in patients that received an ABT was com-
parable in patients that were anemic at admission
(24.3%) compared to the non-anemic (19.6%, p = 0.26).
In patients that did not receive an ABT mortality was
higher in anemic (16.7%) than in non-anemics (9.9%,
p = 0.07).
Table 2 Relative risks for different outcome measures in




n = 536 n = 726
Mortality
In-hospital 30 (5.6) 31 (4.3) 1.17 (0.90-1.52) 0.277
3-month 113 (21.1) 87 (12.0) 1.42 (1.23-1.64) < 0.001
3-12 month 60 (11.2) 71 (9.8) 1.09 (0.89-1.33) 0.415
12-month 173 (32.3) 158 (21.8) 1.34 (1.18-1.53) < 0.001
Delirium 162 (30.3) 155 (21.3) 1.29 (1.13-1.48) < 0.001
LOS > 11 days 272 (50.7) 368 (50.7) 1.00 (0.88-1.14) 0.984
Discharge to a
NH




69 (12.9) 65 (9.0) 1.24 (1.04-1.49) 0.025
Values are given as number (percentage), RR = relative risk, CI = confidence
interval, LOS = length of stay, NH = nursing home
Table 3 Risk factors with a significant HR for mortality
and a significant OR for the other outcome parameters




in-hospital Age in years 1.07 1.02 to 1.11 0.002
ASA 2.76 1.66 to 4.59 < 0.001
ABT 1.88 1.12 to 3.14 0.017
3-month Age in years 1.06 1.04 to 1.09 < 0.001
ASA 1.94 1.47 to 2.57 < 0.001
ABT 1.48 1.10 to 2.01 0.011
Anemia 1.30 0.96 to 1.76 0.088
3-12 month Age in years 1.05 1.02 to 1.08 < 0.001
ASA 1.78 1.26 to 2.52 0.001
12-month Age in years 1.06 1.04 to 1.08 < 0.001
ASA 1.89 1.52 to 2.34 < 0.001
ABT 1.42 1.13 to 1.77 0.002
Delirium Age in years 1.06 1.04 to 1.08 < 0.001
ASA 1.47 1.11 to 1.93 0.006
ABT 1.67 1.28 to 2.20 < 0.001
Male gender 1.99 1.49 to 2.66 < 0.001
LOS > 11 days Anemia 0.63 0.48 to 0.81 < 0.001
Age in years 1.07 1.05 to 1.08 < 0.001
ABT 2.26 1.73 to 2.94 < 0.001
ASA 1.24 0.97 to 1.59 0.089
Discharge to a NH Anemia 1.41 1.10 to 1.81 0.007
Age in years 1.05 1.04 to 1.07 < 0.001
General
anesthesia
1.67 1.05 to 2.64 0.029
Male gender 0.75 0.58 to 0.99 0.038
ABT 1.24 0.96 to 1.61 0.097
90-day
readmission rate
Anemia 1.61 1.11 to 2.33 0.011
Age in years 0.97 0.94 to 0.99 0.006
ASA 1.43 0.99 to 2.09 0.060
General
anesthesia
0.35 0.13 to 0.99 0.047
Female gender, ASA classification I-II, having no anemia, receiving no
allogeneic blood transfusion and spinal anesthesia are reference categories.
* Expressed in HR (Hazard Ratio), all other risk factors in OR (Odds Ratio)
CI = confidence interval, LOS = length of stay, NH = nursing home, ASA =
American Society of Anesthesiologists Physical Status classification, ABT =
allogeneic blood transfusion.
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The RR for 3-month mortality in patients receiving an
ABT was comparable between anemic patients (RR =
1.45, CI 1.02-2.06, p = 0.035) and non-anemic patients
(1.97, CI 1.32-2.95, p = 0.001).
Discussion
In the current study we demonstrate that receiving an
ABT, an ASA classification III/IV and higher age were
risk factors for postoperative mortality. In the same ana-
lysis, anemia at admission was a significant risk factor
for discharge to a nursing home and readmission within
90 days, but not for a higher mortality. LOS in anemic
patients, corrected for age and ABT, was shorter.
Finally, receiving an ABT was correlated with a longer
LOS and a higher delirium incidence.
Anemic versus non-anemic patients
The incidence of anemia and the rate of ABTs in this
cohort were consistent with previous studies in hip frac-
ture patients [6-9,11-14].
Anemic patients were more likely to be older and to
be men, to have a trochanteric fracture and a higher
ASA score and to receive an ABT; the latter two results
were demonstrated by others as well [7,8]. These studies
[7,8] could not find a difference in gender distribution,
one other could [6]. Others have shown that higher age,
female gender and worse health status are correlated to
intertrochanteric fractures [20-22]. These findings show
the complex correlation between anemia as a mirror of
a poor general condition (expressed in higher ASA
scores), age and fracture type and gender
Multivariable logistic and Cox regression analysis
We found anemia not to be a significant risk factor for
mortality in Cox regression analysis, in contrast to sev-
eral other studies [6-9]. However, the largest of these
studies contained only 791 patients and some methodo-
logical concerns could be identified [6]. We consider
anemia therefore to be more a proxy for frailty than a
direct cause related to mortality.
Receiving an ABT was a risk factor for mortality at all
follow-up moments, but not for the 3 to 12 months
interval with its main effect in the first 3 months.
Mortality in transfused hip fracture patients was either
higher or equal in previous series [10-14]. The two lar-
gest series were described by Johnston et al (n = 3571)
and Carson et al (n = 8787) [12,14]. Johnston et al
found a negative correlation at 120 and 365 days in uni-
variate, but not in in multivariable analysis [12]. Carson
et al found no effect on 30- and 90-day mortality [14].
In contrast, fewer complications were seen in restrictive
ABT regimen patients who had total hip and knee repla-
cements [23].
Age and ASA classification as risk factors for mortality
and poor outcome do not need further explanation; the
negative effect of the latter in hip fracture patients has
recently been published [24].
Younger patients with anemia who received no ABT
had a shorter LOS in our series. LOS is more often
reported upon in studies on anemia than in those on
ABTs [7-14]. Gruson, and Halm found a longer LOS in
anemic patients, whereas Hagino did not [7-9]. The only
study on ABT in hip fracture patients that reported
LOS found no difference [10]. Younger age is most
probably the reason for the shorter LOS, not anemia or
receiving no ABT.
Figure 1 mortality in patients that did not receive an
allogeneic blood transfusion (ABT).
Figure 2 mortality in patients that received an allogeneic
blood transfusion (ABT).
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Receiving an ABT did and anemia did not have a
negative effect on delirium incidence in this series.
None of the studies on anemia and ABTs in hip fracture
patients we found, reported delirium incidence. We
would have expected anemia to be of negative influence
as well, because higher age and ASA classification and
male gender were negative contributors; all part of the
the anemic patient profile. This is probably due to the
fact that delirium occurs as a result of many more fac-
tors, like cognitive impairment and medication.
Finally, anemia at admission was of negative contribu-
tion to the 90-day readmission rate, ABT was not. Halm
et al reported on readmissions, they found a lower 60-
day readmission rate in patients with a higher hemoglo-
bin level and in those receiving an ABT [9,13]. These
different findings are probably due to the fact anemia
and an ABT are only two minor of the many factors
influencing the readmission rate.
Anemia effecting ABT and vice versa
As demonstrated, receiving an ABT had a rescue effect
on mortality in anemic patients in the first 3 months.
This was probably partly due to correction of the nega-
tive effect of anemia at admission. The RR for 3-month
mortality in patients receiving an ABT was comparable
between anemic and non-anemic patients; both groups
are negatively affected by an ABT.
Limitations
Our study had a large sample size and the combined ana-
lysis of both anemia at admission and ABTs has never
been done before. Limitations were that part of the data
was collected retrospectively and documentation of
occurrence of a delirium was based on clinical observa-
tions as described in the DSM-IV [16]. Although these
criteria are sufficient, it is better to use a specific delirium
score like the Confusion Assessment Score [25].
The time interval from fracture to admission is no of
influence on the measured hemoglobin level at admis-
sion since in the Netherlands the mean interval between
an accident and admission is no longer than a few
hours.
Several limitations of the analysis for the impact of
receiving an ABT can be identified. The number of
ABTs was not reliably registered in the large majority of
the patients, which made an interesting extra analysis
using the number of transfusions not valid. For male
and female patients different cut-off points for anemia
(defined by the WHO) were used, but the transfusion
threshold was not different [17,19]. Furthermore, the
decision in daily clinical practice to give an ABT is not
only based on the transfusion thresholds, but on clinical
aspects as well as defined in the CBO guideline [19].
However, this represents daily practice for most
hospitals.
Because of these limiting factors we will not presume
a causal link between mortality and the other outcome
parameters and receiving an ABT but we rather call it
“postoperative anemia necessitating a transfusion,
PANT” as a reflection of the whole of the condition of
the patient that needs an ABT postoperatively.
The outcome of this study can be used for better
inform consent, to perform early interventions for pre-
vention of a delirium, to anticipate for a longer LOS
and to provide an alternative discharge location early in
patients at risk.
Finally, awaiting the results of large trials on ABTs
like the FOCUS trial [26], it might be of benefit to use a
lower cut-off transfusion threshold in hip fracture
patients that are in a worse condition, like anemia.
Conclusions
This study has demonstrated that anemia at admission
and PANT were independent risk factors for worse out-
come in hip fracture patients. In multivariable regression
analysis, anemia at admission as such had no effect on
mortality, due to a rescue effect of PANT. PANT
affected in-hospital, 3- and 12-month mortality nega-
tively, with the main effect in the first 3 months
postoperatively.
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